Skip to main content
. 2023 Oct 12;7(11):e0265. doi: 10.1097/HC9.0000000000000265

TABLE 1.

Comparison of patients with NASH versus NAFL with respect to histological, clinical, and demographic characteristics

Clinical and demographic characteristics NAFL N = 16 NASH N = 26
Age, mean (SD) 51.3 (12.8) 50.4 (10.0)
Male, n (%) 15 (94) 21 (81)
Race/ethnicity
 Non-Hispanic White 16 (100) 19 (73)
 Non-Hispanic Black 0 (0) 1 (4)
 Hispanic 0 (0) 2 (8)
 Other 0 (0) 4 (15)
BMI, kg/m2 (SD) 33.9 (5.8) 33.6 (5.2)
Diabetes, n (%) 4 (25) 16 (62)
Fasting blood levels, mean (SD)
 ALT (U/L) 48.9 (24.2) 98.5 (39.3)a
 AST (U/L) 36.6 (26.0) 58.3 (25.7)b
 Total cholesterol (mg/dl) 198.2 (46.4) 206.8 (39.6)
 LDL-C (mg/dl) 104.3 (30.0) 116.4 (41.9)
 HDL-C (mg/dl) 43.6 (20.7) 39.4 (11.9)
 Triglyceride (mg/dl) 269.2 (256.0) 264.3 (99.9)
 Platelet count (K/μl) 230.9 (49.2) 227.4 (60.4)
Hepatic histology, n (%)
 Steatosis gradea
  0 0 (0) 0 (0)
  1 9 (56) 1 (4)
  2 6 (38) 16 (62)
  3 1 (6) 9 (34)
 Inflammation gradea
  0 3 (19) 0 (0)
  1 13 (81) 11 (42)
  2 0 (0) 14 (54)
  3 0 (0) 1 (4)
 Ballooning degenerationa
  0 11 (69) 1 (4)
  1 5 (31) 11 (42)
  2 0 (0) 14 (54)
 Fibrosis stagea
  0 16 (100) 2 (8)
  1 0 (0) 13 (52)
  2 0 (0) 5 (20)
  3 0 (0) 4 (16)
  4 0 (0) 1 (4)

Notes: Data are expressed as mean, and numbers within parenthesis represent either SD or percentage of patients.

a

p<0.01 different between NASH and simple steatosis.

b

p<0.05.

p-value from unpaired 2-tailed Student t-test.